Variable | All patients (n = 60) | NARST (n = 47) | NASST (n = 13) | MDR-ST (n = 22) | NonMDR-ST (n = 38) |
---|---|---|---|---|---|
MIC ciprofloxacin, μg/mL | 0.33 ± 0.21 | 0.37 ± 0.21* | 0.17 ± 0.14* | 0.37 ± 0.26 | 0.30 ± 0.18 |
MIC ceftriaxone, μg/mL | 0.036 ± 0.016 | 0.038 ± 0.018 | 0.031 ± 0.01 | 0.033 ± 0.017 | 0.039 ± 0.016 |
Fever clearance time, days | 5.1 ± 3.5 | 5.5 ± 3.8 | 3.7 ± 1.3 | 4.9 ± 2.7 | 5.3 ± 3.9 |
Total duration of illness, days | 14.3(9.8–21) | 16.3(11.4–24)* | 9.6(6.8–10)* | 14.5(9.3–21.4) | 14.3(9.9–22) |
Complications † | 11 (18) | 11 (23) | -- | 2 (9) | 9 (24) |